Clinical Trials

Empagliflozin: A Transformative Approach to Diabetes?

A major trial demonstrated the glucose-lowering drug empagliflozin reduces cardiovascular morbidity and mortality in individuals with Type 2 diabetes and existing cardiovascular disease. Clinicians and researchers discuss how it does so and who is most likely to benefit.


Beta-amyloid Research Ignites Treatment Hopes for Alzheimer’s Disease

Results of a phase 1b clinical trial published in Nature reveal scientists may be one step closer to finding a treatment that safely impedes the biological progression of Alzheimer’s disease.


Study Finds Survival Benefit for Lung Cancer Patients Whose Depression Improves

Improving symptoms of depression in lung cancer patients is associated with longer survival, according to a recent study. The findings highlight the need for oncology physicians to address mental health issues their patients may be facing, experts say.


Clarifying the Effect of Smoking on Male Fertility

Recent research demonstrates the chief mechanism by which smoking damages sperm.


Complicating Cognition: Common Prostate Cancer Treatment Associated with Higher Dementia Risk

Androgen deprivation therapy (ADT) is a staple of treatment for prostate cancer, but a recent study adds to a growing body of evidence that it places men at higher risk of cognitive decline.


Alzheimer’s, Antipsychotics and Pneumonia: A Balancing Act

Recent research finds that regardless of the drug selected, physicians should exercise caution when prescribing antipsychotics to Alzheimer’s patients.


That's News

Bone Preservation across the Ages

Osteoporosis leads to a broken bone for approximately half of Caucasian and Asian women older than age 50 in the United States, though bone mass loss begins decades earlier.

Two studies at Purdue University found supplementation with soluble corn fiber...


Studies Spotlight Gains in Physical Activity and Function after Bariatric Procedures

A review of studies by researchers in the United Kingdom and Australia finds patterns of improvement in physical activity and ability 12 months after bariatric surgery.


Spider Venom May Hold Key to Treating IBS

Researchers assessing the role that venom plays in activating nerve fibers involved in pain sensation have uncovered a surprising mechanism that may influence irritable bowel syndrome (IBS)-related pain.


Refining Diet-based Approaches to Lowering Type 2 Diabetes Risk

Not all plant-based foods provide equal benefit in terms of reducing risk of diabetes, a new Harvard study finds.